214 results on '"Drug degradation"'
Search Results
2. Ferromagnetic ZnO nanostructures from an organo zinc complex formulated via Piper Longum L-assisted green synthesis: Multifaceted prospects in photocatalysis, antimicrobial activity, and cell viability studies
- Author
-
John, Daphne Mary, Pillai, Nilesh S., Sivan, Akshay, P, Lasya, P, Archana, Sreekanth, K.M., G, Sivasubramanian, and K.M, Sreedhar
- Published
- 2024
- Full Text
- View/download PDF
3. Role of the Solvent and Ultrasound Irradiation in the Preparation of TiO 2 for the Photocatalytic Degradation of Sulfamethoxazole in Water.
- Author
-
Di Michele, Alessandro, Sassi, Paola, Vivani, Riccardo, Minguzzi, Alessandro, Prati, Laura, and Pirola, Carlo
- Subjects
- *
POLAR solvents , *PHOTOCATALYSTS , *TITANIUM dioxide , *PHOTOCATALYSIS , *SOLVENTS - Abstract
The preparation of titania-based photocatalysts has been largely investigated in the literature. Nevertheless, the study of the influence of different solvents in the synthesis mixture requires further analysis. Addressing this issue, we explored the potential of heterogeneous photocatalysis with nano-sized titanium dioxide (TiO2) synthesized via the sol–gel method with and without ultrasound for the degradation of sulfamethoxazole (SMX) in water. Specifically, we engineered TiO2 nanoparticles within the 20–30 nm range, in order to work in the same particle size range of Evonik P25. The synthesis was conducted in five distinct solvents, n-hexane, decane, isopropanol, ethanol, and 1-octanol, and it was evaluated with the presence and absence of ultrasound. Following synthesis, the powders were thoroughly characterized. When nonpolar solvents were used, the photocatalysts were characterized by the presence of both anatase and brookite phases, while with polar solvents, the only polymorph present was anatase. A different behavior was shown by 1-octanol, where the role of the solvent was so important that US did not affect the final sample features. The samples prepared in ethanol and isopropanol exhibited superior activity compared to those synthesized in other solvents in the SMX photodegradation (about 35% after 6 h), and the effect of US during preparation resulted positive for all solvents (an average increase of SMX photodegradation in the range of 5–10% for the different photocatalysts for each degradation time). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Ertapenem's therapeutic potential for Mycobacterium avium lung disease in the hollow fibre model
- Author
-
Deshpande, Devyani, Srivastava, Shashikant, and Gumbo, Tawanda
- Published
- 2024
- Full Text
- View/download PDF
5. Pharmakogenetik – ein Schritt zur individualisierten Schmerzmedizin
- Author
-
Lagoja, Irene M.
- Published
- 2024
- Full Text
- View/download PDF
6. Review on Recent Advances in the Removal of Organic Drugs by Advanced Oxidation Processes.
- Author
-
Umair, Muhammad, Kanwal, Tayyaba, Loddo, Vittorio, Palmisano, Leonardo, and Bellardita, Marianna
- Subjects
- *
TETRACYCLINES , *REACTIVE oxygen species , *PARTIAL oxidation , *ANTIBIOTIC residues , *OXIDATION , *WATER pollution , *CHEMICAL structure - Abstract
In recent years, due to the high consumption of drugs both for human needs and for their growing use, especially as regards antibiotics, in the diet of livestock, water pollution has reached very high levels and attracted widespread attention. Drugs have a stable chemical structure and are recalcitrant to many treatments, especially biological ones. Among the methods that have shown high efficiency are advanced oxidation processes (AOPs) which are, among other things, inexpensive and eco-friendly. AOPs are based on the production of reactive oxygen species (ROS) able to degrade organic pollutants in wastewater. The main problem related to the degradation of drugs is their partial oxidation to compounds that are often more harmful than their precursors. In this review, which is not intended to be exhaustive, we provide an overview of recent advances in the removal of organic drugs via advanced oxidation processes (AOPs). The salient points of each process, highlighting advantages and disadvantages, have been summarized. In particular, the use of AOPs such as UV, ozone, Fenton-based AOPs and heterogeneous photocatalysis in the removal of some of the most common drugs (tetracycline, ibuprofen, oxytetracycline, lincomycin) has been reported. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Green Magnetic Nanoparticles CoFe 2 O 4 @Nb 5 O 2 Applied in Paracetamol Removal.
- Author
-
Oliveira, Jessica R. P., Ribas, Laura S., Napoli, Jose S., Abreu, Eduardo, Diaz de Tuesta, Jose L., Gomes, Helder T., Tusset, Angelo M., and Lenzi, Giane G.
- Subjects
MAGNETIC nanoparticles ,POINTS of zero charge ,IRRADIATION ,MERCURY vapor ,NIOBIUM oxide ,MAGNETIC materials - Abstract
This study describes the synthesis of an innovative nanomaterial (patent application number BR 1020210000317) composed of cobalt ferrite functionalized in niobium pentoxide CoFe
2 O4 @Nb5 O2 (CFNb), synthesized via green synthesis using tangerine peel extract. The material emphasizes the combination of a magnetic material (which allows for easy recovery after application) with niobium pentoxide (a metal which is abundant in Brazil). CFNb was applied as a catalyst for the paracetamol (PCT) degradation by photocatalysis. The new materials were characterized through surface and pore analysis (SBET , SEXT , Smic , Vmic , and VTOTAL ), photoacoustic spectroscopy (PAS), zero charge point (pHPZC , scanning electron microscopy (SEM/EDS), and X-ray diffraction (XRD). The reaction parameters studied included pH and catalyst concentration. The results indicated that the CFNb nanocatalysts were efficient in the paracetamol degradation, presenting better results in conditions of low pH (close to 2) and low catalyst concentration under irradiation of the 250 W mercury vapor lamp (greater than 28 mW·cm−2 ) at 60 min of reaction. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
8. Thermal Stability and Kinetics of Degradation of Moxonidine as Pure Ingredient vs. Pharmaceutical Formulation.
- Author
-
Baul, Bianca, Ledeţi, Adriana, Cîrcioban, Denisa, Ridichie, Amalia, Vlase, Titus, Vlase, Gabriela, Peter, Francisc, and Ledeţi, Ionuţ
- Subjects
THERMAL stability ,PHARMACEUTICAL technology ,PHARMACOKINETICS ,ANTIHYPERTENSIVE agents ,FOURIER transforms - Abstract
The stability of active pharmaceutical ingredients (APIs) and the corresponding pharmaceutical formulations are nowadays of great importance in pharmaceutical research and technology. The quality of an API or of finished pharmaceutical products (FPPs) is time dependent under the influence of several parameters, such as light and air exposure, temperature, and humidity. Additionally, the stability profile of an API is influenced by the formulation composition, due to the presence of excipients or by the characteristic of the packaging materials. In this sense, the main objective of this study was to analyze the degradation kinetics of the antihypertensive drug moxonidine as a pure ingredient (MOX) and in two different solid mixtures, one corresponding to a pharmaceutical formulation (MOXTAB) and the other to an enriched pharmaceutical formulation in MOX (MOXMIX). As investigation techniques, FTIR (Fourier transform infrared) spectroscopy and TG/DTG/HF analysis were employed, while the thermoanalytical data were processed according to the ASTM E698 kinetic method and the isoconversional methods of Flynn–Wall–Ozawa (FWO) and Friedman (FR). The kinetic methods revealed that the excipients have a stabilizing effect on MOX (in terms of Ea values), but the decomposition mechanism of the samples is complex, according to the results suggested by the analysis of Ea vs. α values. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Peroxymonosulfate Activation by Different Synthesized CuFe-MOFs: Application for Dye, Drugs, and Pathogen Removal.
- Author
-
Fdez-Sanromán, Antia, Lomba-Fernández, Bárbara, Pazos, Marta, Rosales, Emilio, and Sanromán, Angeles
- Subjects
- *
PEROXYMONOSULFATE , *ANTI-inflammatory agents , *RHODAMINE B , *ANTIBACTERIAL agents , *ANTIPYRINE , *DYES & dyeing - Abstract
In this study, three CuFe-MOFs were successfully synthesized by a solvothermal process by changing the ratio of solvents, salts, or temperature. These MOFs named CuFe(BDC-NH2)R, CuFe(BDC-NH2)S, and CuFe(BDC-NH2)D showed rod-shaped, spindle-like, and diamond-like structures, respectively. The CuFe(BDC-NH2)D and CuFe(BDC-NH2)S were found to exhibit an improved PMS activation for Rhodamine B removal attaining levels around 92%. Their effective removal capability was investigated as a function of the pH, catalyst dosage, and the effect of the application of UV radiation. The best degradation system was photo-assisted activation of PMS when CuFe(BDC-NH2)D and CuFe(BDC-NH2)S were used. Under these conditions, the degradation of a mixture of antibiotic and anti-inflammatory drugs (sulfamethoxazole and antipyrine) was evaluated with the results revealing the total degradation of both drugs after 1 h. A higher antibacterial activity was attained with the system CuFe(BDC-NH2)R/PMS due to the high copper content with respect to the others. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Ranitidine: A Proposed Mechanistic Rationale for NDMA Formation and a Potential Control Strategy.
- Author
-
Harmon, Paul
- Subjects
- *
RANITIDINE , *NITROSYL chloride , *DIMETHYLAMINE , *H2 receptor antagonists , *OXIDATION , *CHEMICAL stability , *NITROSATION - Abstract
The formation of N-nitrosodimethylamine (NDMA) in ranitidine hydrochloride drug substance (DS) and drug products has attracted considerable attention over the last few years. The drug structure is unusual in that it contains a vinyl nitro moiety. Although a variety of studies have been carried out to understand how NDMA is formed in the DS solids, a mechanistic description of NDMA formation has remained elusive. A new mechanistic view of NDMA formation is detailed here. Autoxidation of ranitidine can rationalize nitrite ion and dimethylamine liberation from ranitidine. The subsequent nitrosation is argued to be due to conversion of nitrite ion to the gas phase nitrosating agent nitrosyl chloride, NOCl. Oxygen scavenging packaging systems should be able to stop the autoxidation, and thus shut down the nitrite release from ranitidine. Without nitrite release NDMA cannot form. This may provide a practical means to stabilize ranitidine DS and solid dosage formulations against NDMA formation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Electrochemically simple, sensitive, and clean method for monitoring norfloxacin in advanced oxidative processes.
- Author
-
de Oliveira Morais, Crislânia Carla, Magalhães, Keurison Figueredo, dos Santos, Elisama Vieira, Castro, Suely Souza Leal, and Martínez-Huitle, Carlos A.
- Subjects
- *
CONDUCTOMETRIC analysis , *AMPEROMETRIC sensors , *CHEMICAL reactions , *DRUG monitoring , *CARBON fibers - Abstract
• The carbon fiber amperometric methodology is suitable for monitoring NOR degradation. • Analytical sensitivity allows NOR to be quantified during electrolytic degradation. • The CF sensor is not affected by the byproducts of drug electrodegradation. • The method is promising for monitoring the treatment of NOR-contaminated water. In this work, an amperometric analysis strategy using a carbon fiber (CF) rod as an anode was developed to follow the degradation process of the norfloxacin (NOR) molecule via electrochemical advanced oxidation processes (EAOP). The voltammetric study showed that drug oxidation is an irreversible process which involves, in the determining stage of the reaction, a proton and an electron in an EC (electron transfer followed by chemical reaction) mechanism. After optimizing the electroanalytical conditions, CF sensor showed a linear amperometric response at concentrations ranging from 1.6 μmol L−1 to 30.0 μmol L−1, with detection and quantification limits of 0.5 μmol L−1 and 1.8 μmol L−1, respectively, which are sufficient to enable in monitoring the drug during its electrolytic degradation. The results clearly showed that the by-products generated during drug degradation do not interfere with the current signal. Other application scenarios were evaluated, such as the determination of NOR in river waters and in the presence of different drug degradation by-products, obtained after EAOPs in chloride-containing medium, and no interference was observed during the electroanalysis. Therefore, the proposed analytical methodology is promising for monitoring and controlling the treatment of water contaminated with NOR antibiotic. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Green Magnetic Nanoparticles CoFe2O4@Nb5O2 Applied in Paracetamol Removal
- Author
-
Jessica R. P. Oliveira, Laura S. Ribas, Jose S. Napoli, Eduardo Abreu, Jose L. Diaz de Tuesta, Helder T. Gomes, Angelo M. Tusset, and Giane G. Lenzi
- Subjects
advanced oxidation process (AOP) ,innovative nanomaterial ,additive influence ,drug degradation ,green chemistry ,green synthesis ,Chemistry ,QD1-999 - Abstract
This study describes the synthesis of an innovative nanomaterial (patent application number BR 1020210000317) composed of cobalt ferrite functionalized in niobium pentoxide CoFe2O4@Nb5O2 (CFNb), synthesized via green synthesis using tangerine peel extract. The material emphasizes the combination of a magnetic material (which allows for easy recovery after application) with niobium pentoxide (a metal which is abundant in Brazil). CFNb was applied as a catalyst for the paracetamol (PCT) degradation by photocatalysis. The new materials were characterized through surface and pore analysis (SBET, SEXT, Smic, Vmic, and VTOTAL), photoacoustic spectroscopy (PAS), zero charge point (pHPZC, scanning electron microscopy (SEM/EDS), and X-ray diffraction (XRD). The reaction parameters studied included pH and catalyst concentration. The results indicated that the CFNb nanocatalysts were efficient in the paracetamol degradation, presenting better results in conditions of low pH (close to 2) and low catalyst concentration under irradiation of the 250 W mercury vapor lamp (greater than 28 mW·cm−2) at 60 min of reaction.
- Published
- 2023
- Full Text
- View/download PDF
13. Role of Catalysis and Catalytic Agents in Drug Stability
- Author
-
Ghayas, Sana, Qadeer, Kiran, Anwar, Zubair, Akash, Muhammad Sajid Hamid, editor, and Rehman, Kanwal, editor
- Published
- 2020
- Full Text
- View/download PDF
14. Chemical Kinetics and Its Applications in Drug Stability
- Author
-
Fatima, Mutayyba, Akash, Muhammad Sajid Hamid, Rasool, Muhammad Fawad, Rehman, Kanwal, Akash, Muhammad Sajid Hamid, editor, and Rehman, Kanwal, editor
- Published
- 2020
- Full Text
- View/download PDF
15. Photodegradation of Ciprofloxacin antibiotic over TiO2 grown by PEO: ecotoxicity response in Lactuca sativa L. and Lemna minor.
- Author
-
Lima, A. S., Rocha, R. D. C., Pereira, E. C., and Sikora, M. de S.
- Abstract
TiO
2 is one of the most used materials in the photocatalysis of organic pollutants. It can be prepared by different techniques including electrochemical methods. The influence of the structure of TiO2 films grown electrochemically using plasma electrolytic oxidation (PEO) was investigated in terms of the photocatalytic activity. The film microstructure and morphology were analyzed and its influence in photocatalytic response was evaluated by photodegradation of ciprofloxacin (CIP). A strong influence of the synthesis temperature on the structural properties (pore diameter and crystallite size) was observed, which could be correlated with the photocatalytic activity change of the synthesized materials. To correlate the structural to the photocatalytic activity, besides Pareto graphs and analysis, a variable called microstructure ratio-SR (pore diameter/crystallite size) was evaluated. Results have shown the F2020005 film (20 mA cm−2 , 20 °C and 0.05 mol L−1 ) presented the highest photocatalytic activity. As a complementary study, ecotoxicity tests were realized using Lactuca sativa L. seeds and the macrophyte Lemna minor. In these experiments, it was observed that the effluents of the photocatalysis carried out with the materials synthesized by PEO presented lower toxicity, compared to the CIP solution without any treatment. The best results for the degradation of CIP were obtained using films synthesized at higher temperatures. CIP photocatalytic degradation using TiO2 films grown by PEO was effective, generating byproducts of low toxicity. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
16. Fabrication of nano-dandelion magnetic TiO2/CuFe2O4 doped with silver as a highly visible-light-responsive photocatalyst for degradation of Naproxen and Rhodamine B.
- Author
-
Osanloo, Mohammad, Khorasheh, Farhad, and Larimi, Afsanehsadat
- Subjects
- *
NAPROXEN , *ELECTRON-hole recombination , *RHODAMINE B , *BAND gaps , *PHOTODEGRADATION , *LIGHT absorption , *HETEROJUNCTIONS , *SCHOTTKY barrier - Abstract
[Display omitted] • A novel TiO 2 @CuFe 2 O 4 /Ag nano-dandelion magnetic composites were synthesized by hydrothermal and sol–gel method. • CuFe 2 O 4 and Ag improved light absorption and electron charge transfer of composites. • The composites exhibited good photocatalytic activity for degradation of Naproxen and Rhodamine B above 90% • Type II heterojunction mechanism was proposed by performing radical scavenger experiments. • The reusability and recyclability of the photocatalyst and reaction kinetics were investigated. Nano-dandelion TiO 2 and magnetic CuFe 2 O 4 were synthesized with hydrothermal and sol–gel processes, respectively. A series of composites containing different amounts of CuFe 2 O 4 and Ag were also prepared using a photoreduction method. The composites were subsequently used for photodegradation of Naproxen and Rhodamine B under UV–Vis light irradiation. The synthesized photocatalysts were characterized by XRD, FTIR, FESEM, EDX, TEM, BET-BJH, DRS, and PL analyses. XRD and FESEM results confirmed the successful synthesis of the dandelion structure for the composites. The VSM analysis also demonstrated the enhancement of magnetic properties of composites. DRS results indicated that CuFe 2 O 4 loading and Ag doping resulted in a decrease in the band gap energy and enhanced absorption of light in the visible region as compared with pure TiO 2. The presence of CuFe 2 O 4 and Ag also increased charge transfer by decreasing electron-hole recombination rates by creating a Schottky-barrier interface which was indicated by the PL spectra. The composite containing 20% CuFe 2 O 4 and 3% Ag (designated as TC20-3Ag) showed better performance as compared with other photocatalysts for photodegradation of Naproxen (92.56%) and Rhodamine B (91.16%) over a 150-minute reaction time. The sample also exhibited good stability after 5 cycles. The effects of operating parameters such as the pH of the solution, the photocatalyst dosage, and initial pollutant concentration were also investigated. It was found that a pseudo-first-order model adequately described the photodegradation kinetics. The results indicated that superoxide and holes were reactive species, and a possible mechanism for the photodegradation of Naproxen by TC20-3Ag was suggested. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Base-Mediated Oxidative Degradation of Secondary Amides Derived from p-Amino Phenol to Primary Amides in Drug Molecules.
- Author
-
Nanda, Kausik K., Ginnetti, Anthony, and Wuelfing, W. Peter
- Subjects
- *
AMIDES , *PHENOL , *CARBOXYLIC acids , *FUNCTIONAL groups , *MOLECULES - Abstract
One of the most common functional groups encountered in drug molecules is the amide, and the most common degradation pathway for amides is base-mediated hydrolysis to its constituent amine and carboxylic acid. Herein, we report for the first time, a base-mediated oxidative degradation pathway of secondary amides to primary amides. This transformation also represents a novel synthetic methodology, reported for the first time in this work, in transforming secondary amides to primary amides without using any oxidative reagents. The introduction of this mechanism into the pharmaceutical literature is important given that the mechanism and required reactants are present to carry out the chemistry in dosage forms. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
18. Photodegradation of Ciprofloxacin antibiotic over TiO2 grown by PEO: ecotoxicity response in Lactuca sativa L. and Lemna minor
- Author
-
Lima, A. S., Rocha, R. D. C., Pereira, E. C., and Sikora, M. de S.
- Published
- 2022
- Full Text
- View/download PDF
19. Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations
- Author
-
Antonella Iudicello, Filippo Genovese, Valentina Strusi, Massimo Dominici, and Barbara Ruozi
- Subjects
anticancer drugs ,azacitidine ,drug degradation ,limits of use ,practical stability ,in-use stability ,Medicine ,Pharmacy and materia medica ,RS1-441 - Abstract
Stability studies performed by the pharmaceutical industry are principally designed to fulfill licensing requirements. Thus, post-dilution or post-reconstitution stability data are frequently limited to 24 h only for bacteriological reasons, regardless of the true physicochemical stability which could, in many cases, be longer. In practice, the pharmacy-based centralized preparation may require preparation in advance for administration, for example, on weekends, holidays, or in general when pharmacies may be closed. We report an innovative strategy for storing resuspended solutions of azacitidine, a well-known chemotherapic agent, for which the manufacturer lists maximum stability of 22 h. By placing the syringe with the azacitidine reconstituted suspension between two refrigerant gel packs and storing it at 4 °C, we found that the concentration of azacitidine remained above 98% of the initial concentration for 48 h, and no change in color nor the physicochemical properties of the suspension were observed throughout the study period. The physicochemical and microbiological properties were evaluated by HPLC–UV and UHPLC-HRMS analysis, FTIR spectroscopy, pH determination, visual and subvisual examination, and sterility assay. The HPLC-UV method used for evaluating the chemical stability of azacitidine was validated according to ICH. Precise control of storage temperature was obtained by a digital data logger. Our study indicates that by changing the storage procedure of azacitidine reconstituted suspension, the usage window of the drug can be significantly extended to a time frame that better copes with its use in the clinical environment.
- Published
- 2021
- Full Text
- View/download PDF
20. Thermal Stability and Kinetics of Degradation of Moxonidine as Pure Ingredient vs. Pharmaceutical Formulation
- Author
-
Ledeţi, Bianca Baul, Adriana Ledeţi, Denisa Cîrcioban, Amalia Ridichie, Titus Vlase, Gabriela Vlase, Francisc Peter, and Ionuţ
- Subjects
moxonidine ,thermal stability ,kinetic study ,isoconversional methods ,drug degradation - Abstract
The stability of active pharmaceutical ingredients (APIs) and the corresponding pharmaceutical formulations are nowadays of great importance in pharmaceutical research and technology. The quality of an API or of finished pharmaceutical products (FPPs) is time dependent under the influence of several parameters, such as light and air exposure, temperature, and humidity. Additionally, the stability profile of an API is influenced by the formulation composition, due to the presence of excipients or by the characteristic of the packaging materials. In this sense, the main objective of this study was to analyze the degradation kinetics of the antihypertensive drug moxonidine as a pure ingredient (MOX) and in two different solid mixtures, one corresponding to a pharmaceutical formulation (MOXTAB) and the other to an enriched pharmaceutical formulation in MOX (MOXMIX). As investigation techniques, FTIR (Fourier transform infrared) spectroscopy and TG/DTG/HF analysis were employed, while the thermoanalytical data were processed according to the ASTM E698 kinetic method and the isoconversional methods of Flynn–Wall–Ozawa (FWO) and Friedman (FR). The kinetic methods revealed that the excipients have a stabilizing effect on MOX (in terms of Ea values), but the decomposition mechanism of the samples is complex, according to the results suggested by the analysis of Ea vs. α values.
- Published
- 2023
- Full Text
- View/download PDF
21. Elucidating Iron Speciation Tuned by Handling Metal Precursor for more Efficient Designing of Nanostructured Fenton Catalysts.
- Author
-
Elías, Verónica R., Benzaquén, Tamara B., Rodríguez, Pablo A. Ochoa, Cuello, Natalia I., Tolley, Alfredo, and Eimer, Griselda A.
- Subjects
- *
METALS , *GREEN'S functions , *METALWORK , *CHEMICAL species , *SOL-gel processes , *CHEMICAL speciation - Abstract
A thorough analysis about iron speciation in the direct Fe-SBA-15 synthesis by using metal precursors with distinct counter-ions: (NO3)−, (SO4)2−, Cl− and (C5H7O2)− is presented. Long-range hexagonal ordering and high specific areas were achieved for all of silicates. Although a Si/Fe molar ratio of 20 allowed incorporating a similar metal content in the materials, several iron species were formed as a function of metal source. The solids were tested as Fenton catalysts for the paracetamol degradation and the importance of the different developed metal species on the catalytic efficiency could be corroborated. The presence of sulfate groups in the synthesis gel led to more active catalysts. Here, isolated Fe3+ ions, stabilized on the structure by multiple oxygen bridge bonds, could interact more efficiently with H2O2 to generate OH· oxidative species for the degradation of organic molecules. Finally, it was demonstrated that by means of sol–gel method and pH conditions control, it is possible handling the metal precursor to achieve certain chemical species on the surface with a higher catalytic efficiency for Fenton process. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. Enrichment of Relevant Oxidative Degradation Products in Pharmaceuticals With Targeted Chemoselective Oxidation.
- Author
-
Nanda, Kausik K., Mozziconacci, Olivier, Small, James, Allain, Leonardo R., Helmy, Roy, and Wuelfing, W. Peter
- Subjects
- *
SYNTHETIC drugs , *MANUFACTURED products - Abstract
Abstract The ability to produce and isolate relatively pure amounts of relevant degradation products is key to several aspects of drug product development: (a) aid in the unambiguous structural identification of such degradation products, fulfilling regulatory requirements to develop safe formulations (International Conference on Harmonization Q3B and M7); (b) pursue as appropriate safety evaluations with such material, such as chronic toxicology or Ames testing; (c) for a specified degradation product in a late-stage regulatory filing, use pure and well-characterized material as the analytical standard. Producing such materials is often a resource- and time-intensive activity, either relying on the isolation of slowly formed degradation products from stressed drug product or by re-purposing the drug substance synthetic route. This problem is exacerbated if the material of interest is an oxidative degradation product, because typical oxidative stressing (H 2 O 2 and radical initiators) tends to produce a myriad of irrelevant species beyond a certain stress threshold, greatly complicating attempts for isolating the relevant degradation product. In this article, we present reagents and methods that may allow the rapid and selective enrichment of active pharmaceutical ingredient with the desired oxidative degradation product, which can then be isolated and used for purposes described above. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
23. Photocatalytic degradation of amoxicillin using TM doped ZnO nanoparticles synthesized from orange peel extract.
- Author
-
Rana, Garima, Dhiman, Pooja, Sharma, Jayati, Kumar, Amit, and Sharma, Gaurav
- Subjects
- *
ORANGE peel , *FRUIT extracts , *CLAVULANIC acid , *PHOTODEGRADATION , *AMOXICILLIN , *OPTICAL spectroscopy - Abstract
[Display omitted] • Orange peel was utilized for synthesis of TM doped ZnO nanoparticles. • TM doping affected the charge separation of carriers. • Ni doped ZnO nanoparticles exhibited the maximum photocatalytic degradation efficiency. • The synthesized catalysts are highly stable and can be reused for 5 cycles. The present work investigates the degradation of Amoxicillin using ZnO and Fe, Ni, Co doped ZnO nanoparticles synthesized using orange peel extract. The synthesized catalysts were characterised with the help of X-ray diffraction, scanning electron microscopy, UV–Visible and photoluminescence spectroscopy for structural and optical properties and the study of charge transport behaviour of the catalysts. The observed results indicate that the Ni doped ZnO nanoparticles exhibit superior degradation efficiencies of 80.71% and 86.21% under UV light and UV + visible light irradiation. Moreover, the slightly basic environment was found to be favourable for optimizing the degradation efficiency of the catalyst, as confirmed by the pH variation experiment. The scavenging experiments were utilized to reveal the most prominent role of hydroxyl radicals in the degradation of Amoxicillin. Additionally, a mere 10.97% reduction in degradation efficiency was observed after fours cycles of degradation experiment. The plausible pathway of amoxicillin degradation has been included into this study as well. Hence, the transition metal (TM) doped ZnO nanoparticles synthesized through waste orange peels suggest their utilization as efficient photo catalyst in Amoxicillin degradation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
24. Rapid Raman Spectroscopic Analysis of Stress Induced Degradation of the Pharmaceutical Drug Tetracycline
- Author
-
Christian Domes, Timea Frosch, Juergen Popp, and Torsten Frosch
- Subjects
resonance Raman spectroscopy ,drug monitoring ,active pharmaceutical ingredients ,antibiotics ,drug degradation ,decomposition of pharmaceutical products ,Organic chemistry ,QD241-441 - Abstract
Stress factors caused by inadequate storage can induce the unwanted degradation of active compounds in pharmaceutical formulations. Resonance Raman spectroscopy is presented as an analytical tool for rapid monitoring of small concentration changes of tetracycline and the metabolite 4˗epianhydrotetracycline. These degradation processes were experimentally induced by changes in temperature, humidity, and irradiation with visible light over a time period of up to 23 days. The excitation wavelength λexc = 413 nm was proven to provide short acquisition times for the simultaneous Raman spectroscopic detection of the degradation of tetracycline and production of its impurity in small sample volumes. Small concentration changes could be detected (down to 1.4% for tetracycline and 0.3% for 4-epianhydrotetracycline), which shows the potential of resonance Raman spectroscopy for analyzing the decomposition of pharmaceutical products.
- Published
- 2020
- Full Text
- View/download PDF
25. In vitro drug release and in vivo safety of vitamin E and cysteamine loaded contact lenses.
- Author
-
Dixon, Phillip, Fentzke, Richard C., Bhattacharya, Arnab, Konar, Aditya, Hazra, Sarbani, and Chauhan, Anuj
- Subjects
- *
THERAPEUTIC use of vitamin E , *CONTACT lenses , *CYSTEAMINE , *CYSTINOSIS , *EYE drops , *IN vitro studies , *THERAPEUTICS - Abstract
Cystinosis is an orphan disease caused by a genetic mutation that leads to deposition of cystine crystals in many organs including cornea. Ophthalmic manifestation of the disease can be treated with hourly instillation of cysteamine eye drops. The hourly eye drop instillation is tedious to the patients leading to poor compliance and additionally, significant degradation of the drug occurs within one week of opening the bottle, which further complicates this delivery approach. This paper focuses on designing a contact lens to treat the disease with improved efficacy compared to eye drops, and also exploring safety of the drug eluding contact lens in an animal model. Our goal is to design a lens that is safe and that can deliver a daily therapeutic dose of cysteamine to the cornea while retaining drug stability. We show that cysteamine diffuses out rapidly from all lenses due to its small size. Vitamin E incorporation increases the release duration of both ACUVUE ® OASYS ® and ACUVUE ® TruEye TM but the effect is more pronounced in TruEye TM likely due to the low solubility of vitamin E in the lens matrix and higher aspect ratio of the barriers. The barriers are not effective in hydrogel lenses, which along with the high aspect ratio in silicone hydrogels suggests that barriers could be forming at the interface of the silicone and hydrogel phases. The presence of vitamin E has an additional beneficial effect of reduction in the oxidation rates, likely due to a transport barrier between the oxygen diffusing through the silicone channels and drug located in the hydrogel phase. Based on this study, both Acuvue ® OASYS ® and ACUVUE ® TruEye TM can be loaded with vitamin E to design a cysteamine eluting contact lenses for effective therapy of cystinosis. The lenses must be worn for about 4–5 hr. each day, which is less than the typical duration of daily-wear. The vitamin E and cysteamine loaded lenses did not exhibit any toxicity in a rabbit model over a period of 7-days. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
26. Drug Stability Analysis by Raman Spectroscopy
- Author
-
Chetan Shende, Wayne Smith, Carl Brouillette, and Stuart Farquharson
- Subjects
drug stability analysis ,drug degradation ,Raman spectroscopy ,multivariate analysis ,astronaut health ,Pharmacy and materia medica ,RS1-441 - Abstract
Pharmaceutical drugs are available to astronauts to help them overcome the deleterious effects of weightlessness, sickness and injuries. Unfortunately, recent studies have shown that some of the drugs currently used may degrade more rapidly in space, losing their potency before their expiration dates. To complicate matters, the degradation products of some drugs can be toxic. Here, we present a preliminary investigation of the ability of Raman spectroscopy to quantify mixtures of four drugs; acetaminophen, azithromycin, epinephrine, and lidocaine, with their primary degradation products. The Raman spectra for the mixtures were replicated by adding the pure spectra of the drug and its degradant to determine the relative percent contributions using classical least squares. This multivariate approach allowed determining concentrations in ~10 min with a limit of detection of ~4% of the degradant. These results suggest that a Raman analyzer could be used to assess drug potency, nondestructively, at the time of use to ensure crewmember safety.
- Published
- 2014
- Full Text
- View/download PDF
27. Сравнительное исследование стабильности биоаналога экулизумаба и оригинального препарата в условиях экстремальных pH, окислительного стресса и под действием УФ-излучения
- Subjects
Electrophoresis ,Chromatography ,Chemistry ,Isoelectric focusing ,Size-exclusion chromatography ,Degradation (geology) ,Drug degradation ,Stress conditions - Abstract
Studying the degradation profiles of drugs based on recombinant monoclonal antibodies under stress conditions makes it possible to determine the dynamics and mechanisms of degradation processes, identify the products of drug degradation, and reveal differences in the stability of biosimilar drugs for a relatively short test times. This paper proposes a strategy for accelerated (35 days) evaluation of drug stability under stress conditions in comparison between the original product Soliris (Switzerland) and its biosimilar analog PRK-001 (Russia) and describes results of a comparative study of their degradation profiles after exposure to extreme pH, oxidative stress, and UV radiation. Fragments of degraded antibodies were analyzed using mass spectrometry, electrophoresis, capillary isoelectric focusing, and size exclusion chromatography. Both products showed similar degradation profiles and similar changes in the content of isoforms.
- Published
- 2021
- Full Text
- View/download PDF
28. Polysaccharide-Based Nanoparticles for Colon-Targeted Drug Delivery Systems
- Author
-
Yubia De Anda-Flores, Alma C. Campa-Mada, Ana L. Martínez-López, Agustín Rascón-Chu, Elizabeth Carvajal-Millan, Judith Tanori-Cordova, and Jaime Lizardi-Mendoza
- Subjects
chemistry.chemical_classification ,Drug ,colon ,business.industry ,media_common.quotation_subject ,Nanoparticle ,Drug degradation ,QD415-436 ,Pharmacology ,Polysaccharide ,Biochemistry ,chemistry ,Targeted drug delivery ,polysaccharide ,Drug delivery ,drug delivery ,Medicine ,Digestive tract ,nanoparticles ,business ,Oral therapy ,media_common - Abstract
Polysaccharide biomaterials have gained significant importance in the manufacture of nanoparticles used in colon-targeted drug delivery systems. These systems are a form of non-invasive oral therapy used in the treatment of various diseases. To achieve successful colonic delivery, the chemical, enzymatic and mucoadhesive barriers within the gastrointestinal (GI) tract must be analyzed. This will allow for the nanomaterials to cross these barriers and reach the colon. This review provides information on the development of nanoparticles made from various polysaccharides, which can overcome multiple barriers along the GI tract and affect encapsulation efficiency, drug protection, and release mechanisms upon arrival in the colon. Also, there is information disclosed about the size of the nanoparticles that are usually involved in the mechanisms of diffusion through the barriers in the GI tract, which may influence early drug degradation and release in the digestive tract.
- Published
- 2021
29. Reverse Transcriptase Inhibitors Nanosystems Designed for Drug Stability and Controlled Delivery
- Author
-
Fedora Grande, Giuseppina Ioele, Maria Antonietta Occhiuzzi, Michele De Luca, Elisabetta Mazzotta, Gaetano Ragno, Antonio Garofalo, and Rita Muzzalupo
- Subjects
HIV ,antiretrovirals ,nanoformulations ,drug degradation ,drug protection ,Pharmacy and materia medica ,RS1-441 - Abstract
An in-depth analysis of nanotechnology applications for the improvement of solubility, distribution, bioavailability and stability of reverse transcriptase inhibitors is reported. Current clinically used nucleoside and non-nucleoside agents, included in combination therapies, were examined in the present survey, as drugs belonging to these classes are the major component of highly active antiretroviral treatments. The inclusion of such agents into supramolecular vesicular systems, such as liposomes, niosomes and lipid solid NPs, overcomes several drawbacks related to the action of these drugs, including drug instability and unfavorable pharmacokinetics. Overall results reported in the literature show that the performances of these drugs could be significantly improved by inclusion into nanosystems.
- Published
- 2019
- Full Text
- View/download PDF
30. An Adaptable Antibody-Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
- Author
-
Eltahir, M., Laurén, I., Lord, M., Chourlia, A., Dahllund, Leif, Olsson, Anders, Saleh, A., Ytterberg, A. J., Lindqvist, A., Andersson, Oskar, Persson, Helena, Mangsbo, S. M., Eltahir, M., Laurén, I., Lord, M., Chourlia, A., Dahllund, Leif, Olsson, Anders, Saleh, A., Ytterberg, A. J., Lindqvist, A., Andersson, Oskar, Persson, Helena, and Mangsbo, S. M.
- Abstract
The agonistic potentials of therapeutic anti-CD40 antibodies have been profiled in relation to antibody isotype and epitope specificity. Still, clinical impact relies on a well-balanced clinical efficacy versus target-mediated toxicity. As CD40-mediated immune activation must rely on a combination of stimulation of antigen-presenting cells (APCs) alongside antigen presentation, for efficient T cell priming, alternative approaches to improve the therapeutic outcome of CD40-targeting strategies should focus on providing optimal antigen presentation together with CD40 stimulation. Herein, a bispecific antibody targeting CD40 as a means to deliver cargo (i.e., synthetic peptides) into APCs through a non-covalent, high-affinity interaction between the antibody and the cargo peptide, further referred to as the Adaptable Drug Affinity Conjugate (ADAC) technology, has been developed. The ADAC platform demonstrated a target-specific CD4+ and CD8+ T cell expansion in vitro and significantly improved peptide-specific CD8+ T cell proliferation in vivo. In addition, the strategy dramatically improved the in vitro and in vivo half-life of the synthetic peptides. Future applications of ADAC involve pandemic preparedness to viral genetic drift as well as neoepitope vaccination strategies where the bispecific antibody is an off-the-shelf product, and the peptide antigen is synthesized based on next-generation sequencing data mining., QC 20230308
- Published
- 2022
- Full Text
- View/download PDF
31. Metabolic Messengers: endocannabinoids
- Author
-
Arnau Busquets-García, Juan P. Bolaños, Giovanni Marsicano, Agencia Estatal de Investigación (España), European Commission, Ministerio de Ciencia e Innovación (España), Ministerio de Sanidad (España), Junta de Castilla y León, European Research Council, Fondation pour la Recherche Médicale, Canadian Institutes of Health Research, Région Nouvelle-Aquitaine, Agence Nationale de la Recherche (France), Busquets-Garcia, Arnau, Bolaños, Juan P., Marsicano, Giovanni, IMIM-Hospital del Mar, Generalitat de Catalunya, Neurocentre Magendie : Physiopathologie de la Plasticité Neuronale (U1215 Inserm - UB), Université de Bordeaux (UB)-Institut François Magendie-Institut National de la Santé et de la Recherche Médicale (INSERM), Agencia Estatal de Investigación, Conseil Régional Aquitaine, ANR-13-BSV4-0006,NeuroNutriSens,Dissection des mécanismes hypothalamiques impliqués dans la détection du statut nutritionnel et régulation de la prise alimentaire via les interactions entre mTORC1, les mélanocortines et les endocannabinoïdes.(2013), ANR-16-CE37-0010,ORUPS,Représentation sensorielle lors d'états psychotiques(2016), ANR-10-LABX-0043,BRAIN,Bordeaux Region Aquitaine Initiative for Neuroscience(2010), European Project: 260515,EC:FP7:ERC,ERC-2010-StG_20091118,ENDOFOOD(2011), and European Project: 640923,H2020,ERC-2014-PoC,CannaPreg(2015)
- Subjects
Central Nervous System ,Biochemical Phenomena ,Glucose transport ,Endocrinology, Diabetes and Metabolism ,Adipose tissue ,Oxygen consumption ,Signal transduction ,Mitogen activated protein kinase ,Biochemistry ,Drug degradation ,Drug synthesis ,Protein kinase B ,Phospholipase C ,Fatty liver ,Physiology (medical) ,Internal Medicine ,Homeostasis ,Oxidative phosphorylation ,Endocannabinoid ,Protein p53 ,Mammalian target of rapamycin ,Metabolic messenger ,Messenger RNA ,Brain ,Glial biology ,Energy metabolism ,Cell Biology ,Cannabis sativa ,Cannabinoid 1 receptor ,cAMP signaling ,Metabolism ,Liver ,Aerobic metabolism ,Neuronal physiology ,Protein expression ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Rho guanine nucleotide binding protein ,Endocannabinoids - Abstract
Endocannabinoid signalling is considered one of the most important modulatory systems in a whole organism. Research has yielded great insight on the mechanisms that link endocannabinoids and metabolic functions. Here, we provide a brief overview of the metabolic roles of endocannabinoids in tissue, cellular and subcellular-dependent mechanisms. In general, we point out how the central and peripheral control of body energy metabolism likely represents the main function of type-1 cannabinoid receptors. More specifically, we focus on recent advances underlying mechanisms of endocannabinoid control of cell metabolism through the modulation of the functions of specific organelles. While highlighting a historical summary and summarizing past discoveries, this short review aims at proposing future open questions for a field that does not stop surprising researchers with unexpected and exciting discoveries., We also thank all the members of A.B.-G.’s, J.P.B.’s and G.M.’s labs for useful discussions and for their invaluable support. The work of A.B.-G. is supported by: Agencia Estatal de Investigación-FEDER (RTI2018-093667-A-100); the ERC starting Grant (HighMemory, #948217); the IBRO Return Home Fellowships 2019 and the Ramon y Cajal programme (RYC-2017-21776) funded by MCIN/ AEI/10.13039/501100011033 and FSE). The work of J.P.B. is funded by the Agencia Estatal de Investigación (PID2019-105699RB-I00; PDC2021-121013-I00; RED2018‐102576‐T; MCIN/AEI/10.13039/501100011033 & European Union NextGenerationEU/PRTR), Plan Nacional de Drogas (Ministerio de Sanidad; 2020I028) and Junta de Castilla y León (CS/151P20 and Escalera de Excelencia CLU-2017-03). The work of G.M. is funded by: INSERM, European Research Council (Endofood, ERC–2010–StG–260515 and CannaPreg, ERC-2014-PoC-640923, MiCaBra, ERC-2017-AdG-786467), Fondation pour la Recherche Medicale (FRM, DRM20101220445), the Human Frontiers Science Program, Region Nouvelle Aquitaine, Agence Nationale de la Recherche (ANR, NeuroNutriSens ANR-13-BSV4-0006 and ORUPS ANR-16-CE37-0010-01 and BRAIN ANR-10-LABX-0043).
- Published
- 2022
- Full Text
- View/download PDF
32. Determination of Degradation Kinetics and Effect of Anion Exchange Resin on Dissolution of Novel Anticancer Drug Rigosertib in Acidic Conditions.
- Author
-
Patel, Hardikkumar, Maniar, Manoj, Ren, Chen, and Dave, Rutesh
- Abstract
Rigosertib is a novel anticancer drug in clinical development by Onconova therapeutics, Inc. Currently, it is in pivotal phase III clinical trials for myelodysplastic syndrome (MDS) patients. Chemically, it is a sodium salt of weak acid with low solubility in lower pH solutions. In the preliminary studies, it was found that rigosertib is unstable in acidic conditions and forms multiple degradation products. In this research, drug degradation kinetics of rigosertib were studied in acidic conditions. Rigosertib follows pseudo-first-order general acid catalysis reaction. Cholestyramine, which is a strong anion exchange resin, was used to form complex with drug to improve stability and dissolution in acidic conditions. Drug complex with cholestyramine showed better dissolution profile compared to drug alone. Effect of polyethylene glycol was investigated on the release of drug from the drug resin complex. Polyethylene glycol further improved dissolution profile by improving drug solubility in acidic medium. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
33. Effects of cyclodextrins on the chemical stability of drugs.
- Author
-
Popielec, Agnieszka and Loftsson, Thorsteinn
- Subjects
- *
CYCLODEXTRINS in pharmaceutical technology , *DRUG stability , *DRUG solubility , *BETA lactam antibiotics , *DRUG delivery systems - Abstract
Cyclodextrins (CDs) are enabling pharmaceutical excipients that can enhance both solubility and stability of wide variety of drugs in aqueous solutions through formation of drug/CD inclusion complexes where apolar moieties of the drug molecules are located inside the CD cavity. In properly designed pharmaceutical formulations CDs will improve physiochemical properties of lipophilic drugs without affecting their intrinsic ability to permeate biological membranes. Here the effect of CD complexes on the chemical stability of drugs is reviewed. Numerous studies shown that in aqueous solutions CD complexation can hamper hydrolysis, oxidation, photodegradation, isomerization and enzyme catalyzed degradation of dissolved drugs. However, some drugs, such as β-lactam antibiotics, can under certain conditions undergo CD catalyzed degradation in aqueous solutions. Also, some drugs that are stabilized by CDs in aqueous solutions are destabilized by the same CDs in solid dosage forms. Thus, the effects of CDs on drug stability have to be tested and verified in the final drug formulation and under the recommended storage conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
34. Models of antimicrobial pressure on intestinal bacteria of the treated host populations.
- Author
-
VOLKOVA, V. V., CAZER, C. L., GRÖHN, Y. T., and Gröhn, Y T
- Abstract
Antimicrobial drugs are used to treat pathogenic bacterial infections in animals and humans. The by-stander enteric bacteria of the treated host's intestine can become exposed to the drug or its metabolites reaching the intestine in antimicrobially active form. We consider which processes and variables need to be accounted for to project the antimicrobial concentrations in the host's intestine. Those include: the drug's fraction (inclusive of any active metabolites) excreted in bile; the drug's fractions and intestinal segments of excretion via other mechanisms; the rates and intestinal segments of the drug's absorption and re-absorption; the rates and intestinal segments of the drug's abiotic and biotic degradation in the intestine; the digesta passage time through the intestinal segments; the rates, mechanisms, and reversibility of the drug's sorption to the digesta and enteric microbiome; and the volume of luminal contents in the intestinal segments. For certain antimicrobials, the antimicrobial activity can further depend on the aeration and chemical conditions in the intestine. Model forms that incorporate the inter-individual variation in those relevant variables can support projections of the intestinal antimicrobial concentrations in populations of treated host, such as food animals. To illustrate the proposed modeling framework, we develop two examples of treatments of bovine respiratory disease in beef steers by oral chlortetracycline and injectable third-generation cephalosporin ceftiofur. The host's diet influences the digesta passage time, volume, and digesta and microbiome composition, and may influence the antimicrobial loss due to degradation and sorption in the intestine. We consider two diet compositions in the illustrative simulations. The examples highlight the extent of current ignorance and need for empirical data on the variables influencing the selective pressures imposed by antimicrobial treatments on the host's intestinal bacteria. [ABSTRACT FROM PUBLISHER]
- Published
- 2017
- Full Text
- View/download PDF
35. Iron(III)-Mediated Oxidative Degradation on the Benzylic Carbon of Drug Molecules in the Absence of Initiating Peroxides.
- Author
-
Nanda, Kausik K., Blincoe, William D., Allain, Leonardo R., Wuelfing, W. Peter, and Harmon, Paul A.
- Subjects
- *
IRON ions , *CHEMICAL decomposition , *OXIDATION , *HYDROPEROXIDES , *HYDROGEN bonding - Abstract
Metal ions play an important role in oxidative drug degradation. One of the most ubiquitous metal ion impurities in excipients and buffers is Fe(III). In the field of oxidative drug degradation chemistry, the role of Fe(III) has been primarily discussed in terms of its effect in reaction with trace hydroperoxide impurities. However, the role of Fe(III) acting as a direct oxidant of drug molecules, which could operate in the absence of any hydroperoxide impurities, is less common. This work focuses on Fe(III)-induced oxidation of some aromatic drug molecules/drug fragments containing benzylic C-H bonds in the absence of initiating peroxides. Alcohol and ketone degradates are formed at the benzylic carbon atom. The formation of a π-stabilized cation radical is postulated as the key intermediate for the downstream oxidation. Implications are briefly discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
36. Degradation of emerging concern contaminants in water by heterogeneous photocatalysis with Na4W10O32.
- Author
-
Molinari, Alessandra, Sarti, Elena, Marchetti, Nicola, and Pasti, Luisa
- Subjects
- *
WATER pollution , *PHOTOCATALYSIS , *ANTIBIOTICS , *ATMOSPHERIC pressure , *HYDROXYL group - Abstract
Contaminants of emerging concern (CECs), including pharmaceuticals, are frequently detected at low concentrations in natural water and can cause adverse effect in biota, such as antibiotic resistance. Therefore, it is important to reduce their introduction in the environment by increasing their removal efficiency from wastewaters. In this work, a new photocatalytic method for removal of three CECs target molecules (i.e. atenolol, levofloxacin, trimethoprim) from water is proposed. The photoactive species is decatungstate anion both in solution and immobilized on modified silica particles. The degradation process is studied at ambient temperature, atmospheric pressure and at pH values similar to that of natural waters. EPR spin trapping technique and HPLC–MS analysis give evidence that degradation is mediated by OH radicals. The heterogeneous catalyst is stable and can be recycled without a significant loss of efficiency thus opening the possibility of developing new solid materials with interesting photocatalytic performance. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
37. Functional Assay for Measuring Bacterial Degradation of Gemcitabine Chemotherapy.
- Author
-
Sayin S and Mitchell A
- Abstract
Drug biotransformation by the host microbiome can impact the therapeutic success of treatment. In the context of cancer, drug degradation can take place within the microenvironment of the targeted tumor by intratumor bacteria. In pancreatic cancer, increased chemo-resistance against the frontline chemotherapy gemcitabine is thought to arise from drug degradation by the tumor microbiome. This bacterial-drug interaction highlights the need for developing rapid assays for monitoring bacterial gemcitabine breakdown. While chemical approaches such as high-performance liquid chromatography are suitable for this task, they require specialized equipment and expertise and are limited in throughput. Functional cell-based assays represent an alternate approach for performing this task. We developed a functional assay to monitor the rate of bacterial gemcitabine breakdown using a highly sensitive bacterial reporter strain. Our method relies on standard laboratory equipment and can be implemented at high throughput to monitor drug breakdown by hundreds of strains simultaneously. This functional assay can be readily adapted to monitor degradation of other drugs. Key features Quantification of gemcitabine breakdown by incubating bacteria that degrades the drug and subsequently testing the growth of a reporter strain on filtered supernatant. Use of an optimized reporter strain that was genetically engineered to be a non-degrader strain and highly sensitive to gemcitabine. A high-throughput assay performed in microplates that can be adjusted for identifying bacteria with a fast or slow gemcitabine degradation rate. The assay results can be compared to results from a standard curve with known drug concentrations to quantify degradation rate., Competing Interests: Competing interestsThe authors declare no conflicts of interest or competing interests., (©Copyright : © 2023 The Authors; This is an open access article under the CC BY-4.0 license.)
- Published
- 2023
- Full Text
- View/download PDF
38. Carbon nano-onions as potential nanocarriers for drug delivery
- Author
-
Silvia Giordani and Michał Bartkowski
- Subjects
Pharmacology ,Cell biology ,Computer science ,Nanotechnology ,Drug degradation ,Tissue penetration ,Carbon ,Nanostructures ,Inorganic Chemistry ,Chemistry ,Drug Delivery Systems ,Drug delivery ,Animals ,Humans ,Free drug ,Carbon* / administration & dosage ,Carbon* / chemistry ,Nanostructures* / administration & dosage ,Nanostructures* / chemistry ,Nanocarriers ,Carbon nanomaterials ,Cancer - Abstract
Nanocarriers are nano-sized delivery vesicles that can transport desired molecules to a specific location. The utilisation of nanocarriers for targeted drug-delivery is an emerging field that aims to solve certain disadvantages of free drug delivery; including premature drug degradation, non-specific toxicity, lack of tissue penetration, undesired side-effects, and multi-drug resistance. The nanocarrier approach has proven effective in this regard, with some examples of FDA approved nanocarrier systems available on the market. In this perspective, we investigate the potential of carbon nano-onions (CNOs) as nanocarriers for drug delivery. The various criteria and considerations for designing a nanocarrier are outlined, and we thoroughly discuss how CNOs fit these criteria. Given the rapidly developing interest in CNOs, this perspective provides a baseline discussion for the use of this novel carbon nanomaterial as a potential nanocarrier for drug delivery.
- Published
- 2021
- Full Text
- View/download PDF
39. Complexation Properties of ß-Cyclodextrin Sulfobutylether Sodium Salt
- Author
-
Loftsson, Thorsteinn, Másson, Már, Labandeira, J. J. Torres, editor, and Vila-Jato, J. L., editor
- Published
- 1999
- Full Text
- View/download PDF
40. Niosomes: Potential Nanocarriers for Drug Delivery
- Author
-
Vijay Mishra, Manvendra Singh, Pallavi Nayak, Ashish Suttee, and Pavani Sriram
- Subjects
Liposome ,Chemistry ,Vesicle ,Drug delivery ,Nanotechnology ,Drug degradation ,Delivery system ,Niosome ,Nanocarriers ,Pharmacology, Toxicology and Pharmaceutics (miscellaneous) ,Bioavailability - Abstract
Niosomes are novel vesicular drug delivery systems, where the solution is surrounded by non-ionic surfactant vesicles. The niosomes offer different benefits over the traditional drug delivery system. Niosomes are structurally similar to liposomes, as they also consist of a bilayer. In the case of niosomes, the bilayer consists of non-ionic surface-active agents instead of phospholipids, as seen in liposomes. Niosomes are much more stable during the process of formulation and storage, as compared to liposomes. Niosomes may resolve the issues of insolubility, volatility, poor bioavailability, and rapid drug degradation. It has been discovered in recent years that, these vesicles can enhance drug bioavailability and can act as a new strategy to deliver many conventional therapeutic agents, such as, protein drugs, and gene materials. It is also easy to prepare and scale up this novel delivery system with low production costs. The delivery of drugs via niosomal formulations may be relevant to several pharmacological agents for their activity against different diseases. The present review provides an overview about the advantages and disadvantages, fabrication techniques, types, characterization technique, and different applications of niosomes.
- Published
- 2020
- Full Text
- View/download PDF
41. Analytical Challenges in Development of Chemoresistance Predictors for Precision Oncology
- Author
-
Sergey N. Krylov, Vasilij Koshkin, Geoffrey Liu, and Mariana Bleker de Oliveira
- Subjects
Oncology ,0303 health sciences ,medicine.medical_specialty ,Chemistry ,Treatment options ,Antineoplastic Agents ,Drug degradation ,Disease ,DNA Damage Repair ,3. Good health ,Analytical Chemistry ,03 medical and health sciences ,0302 clinical medicine ,Drug Resistance, Neoplasm ,Precision oncology ,Chemotherapy Drugs ,Neoplasms ,030220 oncology & carcinogenesis ,Internal medicine ,medicine ,Humans ,Disease biomarker ,030304 developmental biology - Abstract
Chemoresistance, i.e., tumor insensitivity to chemotherapy, shortens life expectancy of cancer patients. Despite the availability of new treatment options, initial systemic regimens for solid tumors are dominated by a set of standard chemotherapy drugs, and alternative therapies are used only when a patient has demonstrated chemoresistance clinically. Chemoresistance predictors use laboratory parameters measured on tissue samples to predict the patient's response to chemotherapy and help to avoid application of chemotherapy to chemoresistant patients. Despite thousands of publications on putative chemoresistance predictors, there are only about a dozen predictors that are sufficiently accurate for precision oncology. One of the major reasons for inaccuracy of predictors is inaccuracy of analytical methods utilized to measure their laboratory parameters: an inaccurate method leads to an inaccurate predictor. The goal of this study was to identify analytical challenges in chemoresistance-predictor development and suggest ways to overcome them. Here we describe principles of chemoresistance predictor development via correlating a clinical parameter, which manifests disease state, with a laboratory parameter. We further classify predictors based on the nature of laboratory parameters and analyze advantages and limitations of different predictors using the reliability of analytical methods utilized for measuring laboratory parameters as a criterion. Our eventual focus is on predictors with known mechanisms of reactions involved in drug resistance (drug extrusion, drug degradation, and DNA damage repair) and using rate constants of these reactions to establish accurate and robust laboratory parameters. Many aspects and conclusions of our analysis are applicable to all types of disease biomarkers built upon the correlation of clinical and laboratory parameters.
- Published
- 2020
- Full Text
- View/download PDF
42. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review
- Author
-
Anamaria Mendonça Santos, Caio de Alcântara Campos, Monna Lisa Barreto Queiroz, Adriano Antunes de Souza Araújo, Saravanan Shanmugam, Lana Naiadhy Silva Santos, Mairim Russo Serafini, and Mayrton Santos Batista
- Subjects
Biocompatibility ,Skin Absorption ,Pharmacology ,Administration, Cutaneous ,01 natural sciences ,Patents as Topic ,03 medical and health sciences ,Drug Delivery Systems ,0302 clinical medicine ,Drug Discovery ,Animals ,Humans ,Technology, Pharmaceutical ,Medicine ,Skin ,Transdermal ,business.industry ,food and beverages ,Drug degradation ,General Medicine ,0104 chemical sciences ,Bioavailability ,010404 medicinal & biomolecular chemistry ,Needles ,030220 oncology & carcinogenesis ,Drug delivery ,business - Abstract
Introduction: The most conventional drug delivery systems exist with limitations such as drug degradation, toxicity and low bioavailability. Also, hypodermic injections can cause pain, compromising...
- Published
- 2020
- Full Text
- View/download PDF
43. Photodegradation of aqueous argatroban investigated by LC/MSn: Photoproducts, transformation processes and potential implications.
- Author
-
Secrétan, Philippe-Henri, Karoui, Maher, Bernard, Mélisande, Ghermani, Noureddine, Safta, Fathi, Yagoubi, Najet, and Do, Bernard
- Subjects
- *
ANTICOAGULANTS , *INTRAVENOUS therapy , *PHOTODEGRADATION , *LIQUID chromatography-mass spectrometry , *DRUG storage - Abstract
Argatroban (ARGA), used as intravenous anticoagulant drug, has been reported to photodegrade under light exposure, requiring specific precautions at handling, storage and administration. Thus, for the first time, aqueous ARGA photodegradation under aerobic conditions has been described in terms of photoproducts, phototransformation processes and potential implications. ARGA significant photoproducts were successfully separated and characterized by gradient reversed-phase liquid chromatography coupled with high-resolution multistage mass spectrometry (LC/HR–MS n ). Hitherto still not available in literature, ARGA in-depth fragmentation study was conducted so as to thoroughly sort out the main mechanisms specific to the molecule and therefore, to propose a fragmentation pattern relevant to the identification of ARGA related substances. Thereafter, in view of the structural characteristics of the photoproducts formed, ARGA photodegradation pathways could be worked out, showing that whether by direct photolysis or through photosensitization, the methyltetrahydroquinoline nitrogen and that of guanidine group would be mainly involved in photolysis initiation reactions, through one-electron oxidation along with proton loss. Desulfonation, cyclisation affording compounds of diazinane type, and/or rearrangements with transfer of the methyltetrahydroquinoline group toward the guanidine function were observed accordingly. Having a good insight into ARGA photodegradation pathways allows for consistent measures in view of mitigating or avoiding the drug decay and the related potential effects. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
44. Simultaneous determination and stability studies of linezolid, meropenem and vancomycin in bacterial growth medium by high-performance liquid chromatography.
- Author
-
Wicha, Sebastian G. and Kloft, Charlotte
- Subjects
- *
LINEZOLID , *MEROPENEM , *DRUG stability , *BACTERIAL growth , *PHARMACOKINETICS , *HIGH performance liquid chromatography , *IN vitro studies - Abstract
For pharmacokinetic/pharmacodynamic (PK/PD) assessment of antibiotics combinations in in vitro infection models, accurate and precise quantification of drug concentrations in bacterial growth medium is crucial for derivation of valid PK/PD relationships. We aimed to (i) develop a high-performance liquid chromatography (HPLC) assay to simultaneously quantify linezolid (LZD), vancomycin (VAN) and meropenem (MER), as typical components of broad-spectrum antibiotic combination therapy, in bacterial growth medium cation-adjusted Mueller-Hinton broth (CaMHB) and (ii) determine the stability profiles of LZD, VAN and MER under conditions in in vitro infection models. To separate sample matrix components, the final method comprised the pretreatment of 100 μL sample with 400 μL methanol, the evaporation of supernatant and its reconstitution in water. A low sample volume of 2 μL processed sample was injected onto an Accucore C-18 column (2.6 μm, 100 × 2.1 mm) coupled to a Dionex Ultimate 3000 HPLC+ system. UV detection at 251, 240 and 302 nm allowed quantification limits of 0.5, 2 and 0.5 μg/mL for LZD, VAN and MER, respectively. The assay was successfully validated according to the relevant EMA guideline. The rapid method (14 min) was successfully applied to quantify significant degradation of LZD, VAN and MER in in vitro infection models: LZD was stable, VAN degraded to 90.6% and MER to 62.9% within 24 h compared to t = 0 in CaMHB at 37 °C, which should be considered when deriving PK/PD relationships in in vitro infection models. Inclusion of further antibiotics into the flexible gradient-based HPLC assay seems promising. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
45. Nanostructured Lipid Carriers for the Formulation of Topical Anti-Inflammatory Nanomedicines Based on Natural Substances
- Author
-
Ana Beatriz Caribé dos Santos Valle, Frederico Pittella, Camila Quinetti Paes, Kézia Cristine Barbosa Ferreira, and Guilherme Diniz Tavares
- Subjects
chemistry.chemical_classification ,Reactive oxygen species ,Antioxidant ,integumentary system ,topical nanomedicines ,natural products ,anti-inflammatory substances ,medicine.medical_treatment ,nanostructured lipid carriers ,Pharmaceutical Science ,Drug degradation ,Review ,Pharmacology ,Drug penetration ,RS1-441 ,Pharmacy and materia medica ,chemistry ,Drug delivery ,medicine ,Topical anti-inflammatory ,Function (biology) - Abstract
The main function of the skin is to protect the body from the external environment. However, the skin can undergo inflammatory processes, due to genetic, hormonal, or environmental factors. When the defense system is overloaded, there is an increase in pro-inflammatory mediators and reactive oxygen species (ROS), which results in skin disorders. Among the substances used to treat these inflammatory processes, many natural substances with anti-inflammatory and antioxidant properties are being studied: nature is yet an abundant source to obtain diverse pharmacological actives. The treatment of skin diseases is usually focused on topical application, as it reduces the risk of systemic side effects and prevents drug degradation by first-pass metabolism. Thus, the properties of drug delivery vehicles can facilitate or inhibit its permeation. Due to the hydrophobic nature of the skin, a promising strategy to improve dermal drug penetration is the use of lipid-based nanoparticles, such as nanostructured lipid carriers (NLC). Therefore, in this review, we present NLC as a tool to improve dermal administration of natural substances with anti-inflammatory properties.
- Published
- 2021
46. Evaluation of bacteriostatic potency of expired oral paediatric antibiotics and implications on infant health
- Author
-
Adenike Ogunshe and Patience Adinmonyema
- Subjects
antibiotic resistance ,drug allergy ,drug degradation ,drug toxicity ,expired antibiotics ,infant mortality ,paediatric antibiotics ,paediatric health ,Medicine - Abstract
INTRODUCTION: in spite of significant risks, as well as non-clinical importance due to loss of potency, stiff penalties against administration of expired medications are still not appropriately enforced by health policy makers in many developing countries, possibly because of little evidence to support that expired medications are hazardous. The purpose of this study therefore, was to investigate the effect of expiration dates on in vitro bacteriostatic potentials of oral paediatric antibiotics. METHODS: comparative bacteriostatic potentials of 31 expired and seven corresponding unexpired oral paediatric antibiotics were determined on infantile diarrhoeagenic bacteria, using a modification of agar well-diffusion method. RESULTS: verall total percentage in vitro resistance rates against expired and unexpired paediatric antibiotics respectively were - E. coli (d"100% vs. d"15.9%), Klebsiella pneumoniae (d"100% vs. d"31.3%), Proteus mirabilis (d"91.7% vs. d"41.7%) and Staphylococcus aureus (d"100% vs. d"18.2%). Resistance rates of 45.5-55.8% (sulfamethoxazole + trimethoprim 5), 39.5-63.6% (amoxycillin 6), 46.5-54.5% (cotrimoxazole 7), 37.5-63.6% (ampicillin + cloxacillin 18), and higher resistance rates of e"75.0-100% were exhibited towards remaining expired antibiotics. Higher total resistance and multiple antibiotic resistance (MAR) rates were also recorded against expired antibiotics (45.2-93.5%) compared to unexpired antibiotics (28.6-57.2%), except for few strains of E. coli and Proteus mirabilis. Furthermore, unexpired paediatric antibiotics exhibited wider zones of inhibition towards the test diarrhoeagenic bacteria (e"25.0 mm diameter). CONCLUSION: this study provided preliminary microbiological results on the appreciable reduction in in vitro bacteriostatic potentials, as well as higher resistance and multiple antibiotic resistance rates among expired oral paediatric antibiotics on infantile diarrhoeagenic bacteria. Apart from less-efficacy, administration of expired antibiotics can lead to increased antibiotic resistance and clinical treatment failure, as well as adverse drug reactions.
- Published
- 2014
- Full Text
- View/download PDF
47. Aplicação de técnicas de RMN para análise de degradação do fármaco ezetimibe
- Author
-
Silva, Amanda Ferreira da, 1988, Tormena, Cláudio Francisco, 1972, Ferreira, Antonio Gilberto, Oliveira, Luciana Gonzaga de, Universidade Estadual de Campinas. Instituto de Química, Programa de Pós-Graduação em Química, and UNIVERSIDADE ESTADUAL DE CAMPINAS
- Subjects
Ezetimiba ,Ressonância magnética nuclear ,Selective experiments ,Ezetimibe ,Experimentos seletivos ,Degradação de fármacos ,Nuclear magnetic resonance ,Drug degradation - Abstract
Orientador: Claudio Francisco Tormena Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Química Resumo: O Ezetimibe, 1-(4-fluorofenil)-3(R)-[3-(4-fluorofenil)-3(S)-hidroxipropil]-4(S)-(4-hidroxifenil)-2-azetidinona, é bastante estudado por ser utilizado para inibir a absorção de colesterol no intestino e reduzir os níveis de LDL ("low density lipoprotein") no plasma. Este trabalho teve por objetivo aplicar uma gama de experimentos de RMN para avaliar a estabilidade do Ezetimibe em condições de "stress" ácidas e básicas e sob ação do tempo e da temperatura, além de identificar os produtos gerados nessas condições sem a realização de etapas de separação física. Em experimentos de DOSY ("Diffusion-Ordered Spectroscopy"), pequenas diferenças nos coeficientes de difusão entre as espécies moleculares presentes na mistura são suficientes para permitir a obtenção de sub-espectros para todas as espécies, obtendo assim o número de componentes presentes na mistura e a caracterização de cada um deles. Geralmente a aplicação de RMN para o estudo de misturas é evitada devido a sobreposição de sinais, porém isso pode ser contornado de três formas: 1) uso de um núcleo como maior dispersão no espectro, no caso o 19F que já pertence a estrutura do Ezetimibe; 2) uso de sequências de pulso seletivas na dimensão do 13C nos experimentos de HSQC e HMBC que melhoram a resolução por, entre outros fatores, diminuir a janela espectral na região de interesse; 3) uso da sequência de TOCSY seletivo, pois, permite a identificação da rede de spin da qual o sinal irradiado faz parte, sendo possível separar em sub-espectros os sinais pertencentes a cada molécula. Os resultados obtidos foram utilizados para determinar a cinética de degradação, bem como a estrutura de cada um dos componentes presentes na mistura de degradação. Diferentemente do que é proposto na literatura, onde apenas a estrutura do produto majoritário da degradação é caracterizado, em nosso trabalho todos os produtos formados durante o processo de degradação foram identificados e caracterizados Abstract: Ezetimibe, 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxipropyl]-4(S)-(4-hydroxiphenyl)-azetidin-2-one is a strong cholesterol inhibitor, reducing the low density lipoproteins level in the blood plasm. The aim of this work was not only to describe the major¿s structures of the Ezetimibe degradation products in neutral, acid and basic conditions but also to evaluate ezetimibe stability using only NMR techniques in situ (without further physical separation). In DOSY ("diffusion ordered spectroscopy") experiments, small differences in diffusion coefficients between molecular species are enough to obtain the number of sub-spectra for each species, leading to the number of components present in the mixture and allowing the characterization of them. NMR is usually avoided when mixtures are subject of the study because of signal superposition (crowed regions), but this can be solved in three ways: 1) using a nucleus with a larger signal dispersion in the spectra, like 19F present in the ezetimibe structure; 2) using experiments called band-selective or semi-selective HSQC/HMBC which yield a higher resolution than the routine HSQC/HMBC by, among other things, select a shorter spectral window. 3) Using selective TOCSY experiment, which enables the identification of the spin system of the irradiated signal, leading to sub-spectra of each components of the mixture. In the current literature, only the major degradation products is characterized, which is not the case here, where all products formed during ezetimibe degradations processes were characterized, without any extra step of physical separation. The kinetics profiles for the ezetimibe degradations were also determined Mestrado Química Orgânica Mestra em Química CAPES
- Published
- 2021
- Full Text
- View/download PDF
48. Recent advances in mechanical force-assisted transdermal delivery of macromolecular drugs
- Author
-
Dong-Hang Xu, Jian-Qing Gao, Ruxuan Wang, Yihua Xu, and Qiong Bian
- Subjects
business.industry ,Pharmaceutical Science ,Nanotechnology ,Drug degradation ,02 engineering and technology ,Absorption (skin) ,021001 nanoscience & nanotechnology ,Mechanical force ,Administration, Cutaneous ,030226 pharmacology & pharmacy ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Drug Delivery Systems ,Pharmaceutical Preparations ,Needles ,Jet injection ,Stratum corneum ,medicine ,Pharmaceutical sciences ,0210 nano-technology ,business ,Transdermal ,Skin - Abstract
The transdermal delivery of macromolecular drugs has become one of the focused topics in pharmaceutical research since it enables highly specific and effective delivery, while avoiding the pain and needle phobia associated with injection, or incidences like drug degradation and low bioavailability of oral administration. However, the passive absorption of macromolecular drugs via skin is highly restricted by the stratum corneum owing to high molecular weight. Therefore, various strategies have been extensively developed and conducted to facilitate the transdermal delivery of macromolecular drugs, among which, mechanical force-assisted techniques occupy dominant positions. Such techniques include ultrasound, needle-free jet injection, temporary pressure and microneedles. In this review, we focus on recent transdermal enhancing strategies utilizing mechanical force, and summarize their mechanisms, advantages, limitations and clinical applications respectively.
- Published
- 2021
49. Nanomedicine in pulmonary delivery
- Author
-
Shyamal C. Das, R. Shah, Prakash Khadka, Hugh D. C. Smyth, and Shayna L. McGill
- Subjects
Drug ,business.industry ,media_common.quotation_subject ,Nanotechnology ,Drug degradation ,Bioavailability ,Targeted drug delivery ,Drug delivery ,Medicine ,Nanomedicine ,business ,Site of action ,Dosing Frequency ,media_common - Abstract
This chapter discusses the use of nanomedicine for pulmonary drug delivery. Nanomedicines contain nanoparticles. Interest in utilizing nanoparticles has been driven by various unique properties that materials attain when they enter the nanoscale. For example, well-known nanoparticle advantages include targeted drug delivery, enhancing cellular and intracellular delivery, increasing dissolution, and availability of drug. These advantages that have initiated large-scale research efforts in general, have also led the researchers to investigate nanoparticulate systems for respiratory delivery. By using the pulmonary route for drug delivery, one can avoid systemic side effects, utilize relatively mild conditions for low drug degradation, increase efficacy, and reduce dosing frequency by targeted dose to the site of action and obtain relatively noninvasive delivery. In addition, nanoparticles can offer an advantage in case of pulmonary delivery by avoiding their clearance by the macrophages due to their small size, which may be important in minimizing loss of inhaled drugs to maximize the drug retention and bioavailability. This chapter reviews nanoparticle technology, its potential use for lung delivery, the types of systems that have been studied the methodology for nanoparticles production, applications, and the potential safety of these systems.
- Published
- 2021
- Full Text
- View/download PDF
50. Zein-based nanomaterials in drug delivery and biomedical applications
- Author
-
Anurag Kumar Gautam, Hriday Bera, Srimanta Sarkar, Pranesh Kumar, Poonam Parashar, Sudipta Saha, Neelu Singh, and Shubhini A. Saraf
- Subjects
food.ingredient ,Biocompatibility ,Chemistry ,Biomaterial ,Nanotechnology ,Drug degradation ,engineering.material ,Gelatin ,Nanomaterials ,food ,Nanofiber ,Drug delivery ,engineering ,Biopolymer - Abstract
Among various natural biopolymers, gelatin has gained attention of scientists and researchers in various biomedical fields. Gelatin as a biopolymer is bestowed with numerous advantages, such as ease of availability from the natural resources, excellent stability, biocompatibility, biodegradability, facile fabrication, ability to modify drug release behavior, and capacity to restrain drug degradation by arresting their release before reaching to the target sites. These benefits eventually make gelatin a potential biomaterial for a variety of biomedical applications including drug delivery, biocompatibility, biodegradability, etc. In recent years, numerous gelatin-based nanomaterials in the form of nanoparticles, nanofibers, nanocomplexes, nanocomposites, etc., have been fabricated and their efficacy to deliver various therapeutic agents like small-molecule drugs, proteins and peptides, genes, etc., has been evaluated. These nanoscaffolds have also been used for tissue regeneration, toxicity minimization, and antimicrobial applications. This chapter describes several gelatin-based nanomaterials specifically developed for drug delivery and biomedical applications.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.